Cytokinetics | CYTK - Gross Profit On Sales



Cytokinetics reported 66.77M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 243.83M 19.91M Jun/2025
Amgen USD 6.17B 624M Jun/2025
Bayer EUR 6.38B 1.74B Jun/2025
Biogen USD 2.04B 238.8M Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Cytokinetics 66.77M 165.03M Jun/2025
Eisai JPY 160.05B 12.42B Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
Exelixis USD 548.79M 12.52M Jun/2025
Geron 47.85M 9.45M Jun/2025
Halozyme Therapeutics USD 279.36M 62.9M Jun/2025
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
Ligand Pharmaceuticals USD 72.86M 32.38M Jun/2025
Merck USD 12.99B 224M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Pfizer USD 10.88B 248M Jun/2025
Regeneron Pharmaceuticals USD 3.15B 581M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Sanofi EUR 7.74B 26M Jun/2025